BCL2 and Miyoshi myopathy: Prior preclinical [6,7,8,9] and clinical studies [10,11] have demonstrated that MM cells overexpress anti-apoptotic Bcl-2 and Mcl-1 proteins, which supports their survival by preserving optimal mitochondrial function.